Recent Stories
In Detail As of Sat, July 11, 2026, 09:15 am, America/Chicago
A $1B Acquisition Gives Novartis a Way to Stand Out in Crowded Area of Cancer
Frank Vinluan / medcitynews - Myricx Bio brings to Novartis antibody drug conjugates with a novel cancer-killing payload called an NMT inhibitor. Novartis says Myricx’s drugs could have advantages over currently available ADCs as well as those still in clinical development. The post A…
AI Summary: Novartis has struck a roughly $1 billion deal to acquire Myricx Bio, a preclinical bet aimed at securing a novel antibody‑drug conjugate payload. The move is a clear attempt to stand out in a crowded oncology market by buying potential innovation rather than inventing it in‑house — or, as finance folks call it, buying optionality.
Two tests GPs can soon offer to help spot endometriosis
bbc - Experts hope they will be a game-changer and cut the nine-year or longer diagnosis waits patients can currently face.
AI Summary: Emerging research on hormonal signatures and blood biomarkers has led to development of tests GPs may soon use to spot endometriosis earlier. Patient accounts underline the life‑changing potential of timely diagnosis. The work promises less guesswork, fewer invasive procedures, and fewer years lost to unexplained pain—so yes, medicine might actually make life convenient for once.
Mass General Brigham nurses, home care clinicians launch largest healthcare strike in state history
fiercehealthcare - Contract disputes will keep about 4,000 Brigham and Women's Hospital nurses off the job for five days, and another 450 home care clinicians on picket lines for a week.
AI Summary: Home‑care nurses at Mass General Brigham have walked off the job in a high‑visibility strike demanding better wages and benefits, halting services and forcing preparations across the system. Management and clinicians scramble to maintain patient care continuity as picket lines and negotiations intensify. Unions emphasize staffing and compensation as central unresolved issues.
American Cancer Society Reports Latest Global Cancer Statistics; Cancer Cases Approach 21 Million Worldwide, With Burden Projected to Surge 67% by 2050
cancer - New data reveal stark geographic inequities and call for urgent global action on prevention, early detection, and equitable treatment access
AI Summary: The American Cancer Society published updated global cancer statistics showing cases near 21 million and projecting a steep rise by midcentury, highlighting shifting incidence patterns and growing health system strain. The report calls for intensified prevention, screening and investment in equitable cancer control to blunt the projected surge.
- GLOBOCAN and ACS: New global cancer estimates and projections (6)
- Regional responses: conferences, national programs, and research (4)
- Survival gaps: breast, GI, GU cancers and immunotherapy access (5)
- WHO 2026 Global Cancer Report: Urgent calls for action (5)
- All Other Stories
GLOBOCAN and ACS: New global cancer estimates and projections
Regional responses: conferences, national programs, and research
Survival gaps: breast, GI, GU cancers and immunotherapy access
WHO 2026 Global Cancer Report: Urgent calls for action
All Other Stories
Epic names 4 leaders to step up after Sumit Rana’s exit
Naomi Diaz / beckershospitalreview - Epic named four executives who will take on expanded responsibilities following President Sumit Rana’s departure, according to a statement from Founder and CEO Judy Faulkner shared with Becker’s. Ms. Faulkner said Seth Howard, Mark Lipsky, Erv Walter and …
AI Summary: Epic’s president, Sumit Rana, is stepping away and the company has reorganized senior roles to cover the gap. The reshuffle names multiple leaders to take on expanded responsibilities as Epic navigates an executive transition while reassuring customers and investors that product development and client support will continue uninterrupted.
Ascension to Buy Tennessee Health System for Nearly $1B
Katie Adams / medcitynews - Ascension is set to acquire Williamson Health, a county-owned health system in Tennessee, in a deal worth nearly $1 billion. Ascension’s offer beat out bids from HCA Healthcare and Optum. The post Ascension to Buy Tennessee Health System for Nearly $1B ap…
AI Summary: Ascension announced plans to buy Williamson Health, an independent Tennessee health system, in a transaction valued at roughly $700M–$1B. The acquisition further consolidates hospital ownership in the region and will shift local governance and operational control to Ascension as the parties work through regulatory and integration steps.
Michigan and other states see unusual spike in parasite that causes 'explosive' diarrhea
medicalxpress - A parasite that causes severe, watery diarrhea is spreading across the United States, and health officials in Michigan are racing to explain an unusual surge in cases.
AI Summary: Health officials are investigating an unusual surge in a parasite that causes violent, watery diarrhea, with Michigan among the hardest-hit areas. Public-health teams are tracing exposures, warning vulnerable populations, and urging hygiene measures as cases cluster across multiple states. The outbreak has prompted CDC tracking and local alerts amid rising gastrointestinal illness reports.
- Michigan epicenter: record surge and testing strain (5)
- Nationwide spread, CDC tracking, and safety guidance (4)
Michigan epicenter: record surge and testing strain
Nationwide spread, CDC tracking, and safety guidance
Healthcare workers in Congo strike amid Ebola outbreak: 6 updates
Mariah Taylor / beckershospitalreview - Front-line healthcare workers at the epicenter of the Ebola outbreak in the Democratic Republic of Congo went on strike over a lack of pay and poor working conditions, Reuters reported July 7. Workers from in and outside hospitals said they have worked wi…
AI Summary: Healthcare workers in the Democratic Republic of Congo have launched strike actions amid a surging Ebola outbreak, with fatalities rising and frontline staff protesting working conditions and safety concerns. The walkouts threaten response capacity, complicating efforts to trace contacts, vaccinate and treat patients as authorities scramble to maintain basic outbreak control measures.
Parham Habibzadeh: ctDNA MRD After CRLM Resection Identifies Who Benefits From ACT!
oncodaily - Parham Habibzadeh, Internal Medicine Resident at UPMC, shared a post on X: “JAMA Oncology: ctDNA MRD after CRLM resection identifies who benefits from ACT! Upfront surgery: MRD+ patients improved with […]
AI Summary: A growing body of evidence shows circulating tumor DNA (ctDNA) measured after colorectal liver metastasis resection can identify which patients truly benefit from adjuvant chemotherapy and who likely do not. This blood test promises more personalized postoperative care, reducing unnecessary toxicity and costs by targeting chemo to molecular minimal residual disease rather than gut instinct.
Hospital groups, GPO push back on CMS’ 2027 outpatient rule
Ella Jeffries / beckershospitalreview - Four groups are condemning CMS’ proposed 2027 Hospital Outpatient Prospective Payment System and Ambulatory Surgery Center rule, which would cut what Medicare pays hospitals for 340B drugs and expand site-neutral payments into a new category of services. …
AI Summary: Major hospital groups and purchasing GPOs are pushing back on CMS’ proposed 2027 outpatient payment rule, warning that reimbursement changes could disrupt provider margins, patient access and group purchasing dynamics. CMS’ proposal would alter outpatient payment calculations; hospitals argue the revisions threaten financial viability of some outpatient services and request policy rework and deeper stakeholder engagement.
Ovarian Function Suppression Plus Tamoxifen Significantly Reduces Premenopausal Breast Cancer Recurrence Over Tamoxifen and Further Reduction Is Seen When Combined with Exemestane
esmo - Findings from the SOFT and TEXT studies
AI Summary: A new analysis shows adding ovarian function suppression to tamoxifen substantially lowers recurrence in premenopausal breast cancer patients compared with tamoxifen alone, with even greater reduction when switched to exemestane. Clinicians should note the clear endocrine benefit — and patients can sigh with cautious optimism while weighing menopausal side effects.
Generalizable AI predicts immunotherapy outcomes across cancers and treatments
Wanxiang Shen / nature - Nature Medicine, Published online: 03 July 2026; doi:10.1038/s41591-026-04502-7COMPASS is a pan-cancer foundation model that predicts immunotherapy response, across cancer types and treatments, from bulk tumor transcriptomes.
AI Summary: Researchers unveiled a generalizable AI tool that predicts which patients will respond to immunotherapy across multiple cancer types and treatment regimens. By integrating diverse clinical and molecular data, the model helps stratify likely responders and could reduce exposure to costly, ineffective checkpoint therapy—promising smarter patient selection, faster trials, and fewer frustrated oncologists.
- Broader AI advances in oncology and immunotherapy research (4)
- COMPASS pan-cancer model predicts immunotherapy response (5)
- All Other Stories
Broader AI advances in oncology and immunotherapy research
COMPASS pan-cancer model predicts immunotherapy response
All Other Stories
The US is hooked on unregulated peptides. But are they effective, or even safe?
livescience - The world of peptides has exploded in wellness circles, but the benefits of injecting these gray-market molecules rest on little clinical evidence.
AI Summary: Unregulated peptide products have proliferated in the US, raising safety and efficacy concerns as federal regulators convene a contentious panel that includes proponents of these off‑label compounds. The debate highlights a market gap where hype often outpaces evidence — and where regulators must decide whether to tidy up the wild west or watch it fester.
CAR T cell therapy selectively depletes disease-driving mutant calreticulin cells in xenotransplants and human organoid models of myelofibrosis
Alexandros Rampotas, Zoë C. Wong, Isaac Gannon, Charlotte K. Brierley, Yuqi Shen, Camelia Benlabiod, / science - Science Translational Medicine, Volume 18, Issue 856, July 2026.
AI Summary: Preclinical studies show CAR‑T cells engineered to target mutant calreticulin selectively eliminate disease‑driving clones in xenografts and human organoid models of myelofibrosis. The results reveal a potentially curative approach for a previously intractable mutation‑driven disease, though safety, on‑target effects and clinical translation remain to be rigorously tested.
CheckMate 214 Updates: Nivolumab Plus Ipilimumab Versus Sunitinib in Advanced RCC
oncodaily - First-line treatment for advanced renal cell carcinoma has changed substantially with the use of immune checkpoint inhibitor-based regimens. Long-term follow-up is important to show whether these early survival and response […]
AI Summary: Long‑term CheckMate‑214 data comparing nivolumab plus ipilimumab against sunitinib in advanced renal cell carcinoma show sustained survival benefits for the immunotherapy combination at nine years. The follow‑up reinforces durable responses in a defined subgroup, helping clinicians refine long‑term treatment sequencing and expectations for metastatic RCC.
Anthropic Launches Claude Science to Court Pharma Ahead of IPO
Katie Adams / medcitynews - Anthropic unveiled Claude Science, an AI workbench designed to run — not just assist with — pharma research. The company is seeking to build out its customer base in the pharma sector as it deepens its healthcare push ahead of a widely anticipated IPO.The…
AI Summary: Anthropic has rolled out Claude Science to court pharmaceutical partners and stake a claim in drug discovery, signaling a pivot from conversational AI toward biology and chemistry workflows. The move accelerates competition in AI‑driven target ID and molecule design, promising speed and scale — and giving traditional drug hunters a new set of algorithms to either fear or befriend.
Evernorth unveils new AI-powered specialty pharmacy program, Pharmacy Forward
fiercehealthcare - Evernorth has unveiled a new specialty pharmacy program that leans on AI to support a better experience for patients with complex conditions.
AI Summary: Evernorth announced a $100 million investment to roll out an AI‑driven specialty pharmacy program designed to streamline specialty drug management, improve medication access, and optimize operations. The program blends automation and data analytics to cut friction in high‑cost therapies — promising efficiency gains if the tech behaves, which is always the question.
Orca Bio Cell Therapy Gets Landmark FDA Nod for New Kind of Living Medicine
Frank Vinluan / medcitynews - FDA approval of Orca Bio’s Tregzi makes it the first cell therapy based on regulatory T cells, or Tregs. Clinical trial results showed reduced risk of graft-versus-host disease, a common complication of the allogeneic stem cell transplants that are a stan…
AI Summary: Orca Bio’s off‑the‑shelf allogeneic cell therapy received FDA approval, marking a milestone for engineered living medicines. Regulators cleared the product after pivotal efficacy and manufacturing data, offering broader access to cellular therapy but spotlighting cost, supply logistics and the need for robust post‑market safety surveillance.
Blistering Heat Expected to Persist Into the Fourth of July
Amy Graff and Mark Walker / nytimes - While relief could come to the Great Lakes and the far Northeast over the weekend, the Mid-Atlantic and Southeast will stay hot.
AI Summary: A persistent eastern U.S. heat dome is forecast to last into the Fourth of July, threatening outdoor sporting events and large gatherings with extreme temperatures. Officials urged heat‑safety measures—hydration, shaded rest, altered schedules—and warned that athletes and fans could face heat illness if organizers don’t adapt to the unwelcome, sunny persistence.
- Fourth of July and major events threatened by heat (3)
- Health, safety and physiological effects of extreme heat (5)
Fourth of July and major events threatened by heat
Health, safety and physiological effects of extreme heat
WHO says Hantavirus outbreak linked to ship is over
bbc - The World Health Organization's director general says no further cases have been reported since 25 May.
AI Summary: WHO announced the cruise ship–linked hantavirus outbreak is over after investigations found no ongoing transmission tied to the vessel. Public-health teams closed the incident, lifted emergency measures for passengers and crew, and advised continued targeted surveillance at ports. Travelers can breathe easier — but maybe skip the rodent-themed souvenirs.
American Hospital Association names Steve Walsh as next CEO
fiercehealthcare - Walsh is currently the head of the Massachusetts Hospital Association, and will be taking the national stage at a moment of substantial policy and political challenges for the hospital industry.
AI Summary: Steve Walsh was named the next CEO of the American Hospital Association, replacing outgoing leadership and signaling continuity with a public-sector advocacy background. The appointment centers on navigating hospital policy, membership priorities and advocacy at a time of industry consolidation and regulatory pressure — yes, more meetings and memos ahead.
Incoming Stories
Stories currently below the threshold for inclusion in the main list; they'll either get more attention and move over, or fade away.
StackHealth RSS
You can now follow topics by RSS - browse the complete list of topics, people, and organizations. Or, try Olfaction, Health Disparities, Digital Health, None and look for the RSS link.
StackHealth Time Machine
More StackHealth